Natera, Inc. (NTRA)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Insurance Carriers Revenue	2.36B	2.17B	1.57B
Insurance Carriers Revenue Growth	8.54%	38.13%	64.73%
Laboratory Partners Revenue	111.10M	103.11M	97.21M
Laboratory Partners Revenue Growth	7.74%	6.07%	-1.70%
Patients Revenue	33.20M	31.82M	27.88M
Patients Revenue Growth	4.36%	14.10%	-5.56%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
United States Revenue	2.46B	2.26B	1.66B
United States Revenue Growth	8.54%	36.59%	58.24%
Americas, excluding US Revenue	10.06M	9.35M	6.62M
Americas, excluding US Revenue Growth	7.59%	41.30%	34.88%
Europe, Middle East, India, Africa Revenue	24.86M	24.48M	23.88M
Europe, Middle East, India, Africa Revenue Growth	1.54%	2.50%	4.70%
Asia Pacific and Other Revenue	8.45M	8.01M	8.66M
Asia Pacific and Other Revenue Growth	5.43%	-7.48%	20.04%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Tests Processed	3.68M	3.53M	3.06M
Tests Processed Growth	4.49%	15.04%	22.78%
Tests Accessioned	3.63M	3.47M	3.00M
Tests Accessioned Growth	4.57%	15.55%	23.71%
Tests Reported	3.47M	3.34M	2.93M
Tests Reported Growth	3.81%	14.22%	22.54%
Tests Reported in Laboratory	3.42M	3.29M	2.87M
Tests Reported in Laboratory Growth	3.87%	14.69%	23.41%

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 23, 2026

Data Sources Report a data error